RHB Retail Research

Trading Stocks - Duopharma Biotech

rhboskres
Publish date: Mon, 13 Apr 2020, 09:54 AM
rhboskres
0 9,020
RHB Retail Research

Duopharma Biotech’s buying momentum may have returned after it recovered above the 21-day SMA line lately. Last Friday’s candle sent the stock to its 1-month high, thereby enhancing the bullish sentiment. An upbeat bias may emerge above the MYR1.39 level, with an exit set below the MYR1.35 mark. Towards the upside, the immediate resistance is at the MYR1.53 level, followed by the MYR1.60 threshold.

Source: RHB Securities Research - 13 Apr 2020

Related Stocks
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment